Sector
PharmaceuticalsOpen
₹14.8Prev. Close
₹14.55Turnover(Lac.)
₹0.04Day's High
₹14.84Day's Low
₹14.6152 Week's High
₹26.0152 Week's Low
₹9.4Book Value
₹-2.54Face Value
₹10Mkt Cap (₹ Cr.)
8.55P/E
0EPS
0Divi. Yield
011 Dec 2024
12:00 AM
EGM
2 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
24 Aug 2024
12:00 AM
AGM
Announcement Date: 24 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.85 | 5.85 | 5.85 | 5.85 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -7.56 | -7.42 | -3.2 | -3.92 |
Net Worth | -1.71 | -1.57 | 2.65 | 1.93 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 6.32 | 6.59 | 8.17 | 17.18 |
yoy growth (%) | -3.99 | -19.32 | -52.45 | 1.42 |
Raw materials | -3.03 | -4.87 | -4.61 | -12.75 |
As % of sales | 47.91 | 73.96 | 56.43 | 74.23 |
Employee costs | -1.71 | -1.94 | -1.38 | -1.32 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -1.28 | -3.75 | 0.01 | 0.01 |
Depreciation | -1.02 | -0.42 | -0.72 | -0.95 |
Tax paid | 0 | -0.25 | -0.01 | 0 |
Working capital | -0.42 | -4.52 | 1.6 | -0.11 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -3.99 | -19.32 | -52.45 | 1.42 |
Op profit growth | -93.07 | -485.05 | -29.03 | 183.11 |
EBIT growth | -66.46 | -1,163.58 | 4.51 | -25.64 |
Net profit growth | -65.9 | -2,08,871.63 | -79.24 | -15.55 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,678.3 | 94.02 | 4,02,680.39 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,612.15 | 79.46 | 1,75,531.81 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,464.85 | 24.02 | 1,18,307.2 | 1,485.4 | 1.09 | 4,254.47 | 397.44 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,173.95 | 56.38 | 1,07,416.07 | 474 | 1.01 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,251.75 | 19.53 | 1,04,452.95 | 1,200.7 | 0.64 | 5,546.3 | 345.81 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Dhawal Akhilesh Deopura
Managing Director
SARANG PATHAK
Non Executive Director
Hemant Amrish Parikh
Independent Director
Shivani Pathak
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Adline Chem Lab Ltd
Summary
Adline Chem Lab Limited (Formerly known as Kamron Laboratories Limited) was incorporated in 1988 by its Promoter, Mr Kamlesh J Laskari. The Company name was changed from Kamron Laboratories Limited to Adline Chem Lab Limited effective on October 13, 2021. The Company is engaged primarily in the business of marketing of Pharmaceutical and Nutraceuticals products.In May 1990, the Company started production at its site in Rakanpur, Gujarat. Initially, the Company was manufacturing tablets, capsules and liquid orals. In 1993, it started manufacture of injections. At present, the company is marketing its products in many states of India and also exporting to a few countries. But over the period of last three decades, there were major changes in the manufacturing technology and building layout due to which the companys plant became obsolete. After taking shareholders approval, the company had discontinued the production in 2019 and sold its land and building in December 2019. Currently the company is continuing the marketing activities and getting its products manufactured from various manufacturers.Mr. Hemant A. Parikh acquired the shares of the Company via Open Offer process in October, 2023 and has become the Promoter of the Company in 2023-24.
Read More
What is the Adline Chem Lab Ltd share price today?
The Adline Chem Lab Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹14.61 today.
What is the Market Cap of Adline Chem Lab Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Adline Chem Lab Ltd is ₹8.55 Cr. as of 30 May ‘25
What is the PE and PB ratio of Adline Chem Lab Ltd?
The PE and PB ratios of Adline Chem Lab Ltd is 0 and -5.74 as of 30 May ‘25
What is the 52 Week High and Low of Adline Chem Lab Ltd?
The 52-week high/low is the highest and lowest price at which a Adline Chem Lab Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Adline Chem Lab Ltd is ₹9.4 and ₹26.01 as of 30 May ‘25
What is the CAGR of Adline Chem Lab Ltd?
Adline Chem Lab Ltd's CAGR for 5 Years at 23.92%, 3 Years at 18.64%, 1 Year at -15.16%, 6 Month at -38.35%, 3 Month at -0.41% and 1 Month at 11.78%.
What is the shareholding pattern of Adline Chem Lab Ltd?
The shareholding pattern of Adline Chem Lab Ltd is as follows:
Promoters - 29.61 %
Institutions - 0.00 %
Public - 70.39 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.